Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL

NCT06450145 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Tumour

Interventions

DRUG: interferon α-2b

Sponsor

Zhejiang Provincial People's Hospital

Collaborators

[object Object]